Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
This study aimed to provide accurate estimates of rates of qualitative neuromuscular blockade (NMB) monitoring during surgical
procedures utilizing NMB agents. Residual neuromuscular blockade in patients admitted to the post anesthesia care unit (PACU)
is common, with inadequate postoperative neuromuscular block reversal event rates ranging from 16% to 70%. NMB monitoring
is effective in detecting residual NMB, yet research fi ndings suggest that in patients whom have had NMB agents administered, up
to 40% do not receive intraoperative NMB monitoring. Anesthesia practice guidelines suggest performance of NMB monitoring
when a NMB agent is administered. Despite best practice guidelines recommending NMB monitoring, estimates of the rate of NMB
monitoring are dated and low. In our study, the estimated overall rate of NMB monitoring was 98.9%. No statistically signifi cant
differences in NMB monitoring rates were found for surgery year, provider type (MD/DO or CRNA), patient BMI, patient age,
or length of surgery. There were a disproportionate number of females that had NMB monitoring performed compared to males
(p=0.002). Additionally, there were a disproportionate number of patients aged 40-69 and 70-80+ that had NMB monitoring
performed compared to patients aged 18-39 (p=0.01). Several variables were included in the fi nal logistic regression model as
signifi cant predictors of the lack of NMB monitoring. A Delphi panel recommended future research examining adverse respiratory
events in the PACU to establish a standard of care for quantitative versus qualitative NMB monitoring in the perioperative period